Ultragenyx Pharmaceutical Inc. buy Royal Bank of Canada
Start price
07.07.26
/
50%
€31.15
Target price
07.07.27
€34.97
Performance (%)
-3.60%
Price
09:32
?
Summary
This prediction is currently active. With a performance of -3.60%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 07.07.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Ultragenyx Pharmaceutical Inc. | -3.60% |
| iShares Core DAX® | -0.218% |
| iShares Nasdaq 100 | -2.352% |
| iShares Nikkei 225® | -3.105% |
| iShares S&P 500 | -0.497% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (RARE) had its price target raised by Royal Bank Of Canada from $35.00 to $40.00. They now have an "outperform" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€47.00
06.11.24
06.11.24
€71.64
06.11.25
06.11.25
-42.98%
07.11.25
07.11.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€49.00
26.09.24
26.09.24
€69.10
26.09.25
26.09.25
-49.39%
27.09.25
27.09.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€41.20
22.04.24
22.04.24
€72.35
22.04.25
22.04.25
-22.82%
23.04.25
23.04.25